I think we are on the same page mate. Lots of potential here. To already have the phase 1 trial well underway, and the potential for the next trial to gain drug approval, CHM is a potential pocket rocket.
And then we have the new drug. And then we have other cancer types.
All with a very small SOI and a very competetive market cap.
For now we wait. But this certainly is an exciting company.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.37M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $9.689K | 2.768M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 75 | 71790139 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86946524 | 26 |
View Market Depth
| Last trade - 12.54pm 01/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |